Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 13Other 2Sarcoma 1Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 2Sarcoma 2Radiation Injuries 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Anus Neoplasms 1

Interventions

Gemcitabine 4pembrolizumab 3Docetaxel 3Cryosurgery 3Biopsy 3eribulin 2durvalumab 2balstilimab 2atezolizumab 2aflibercept 2Zoledronic Acid 2Trastuzumab 2Taxes 2Specimen Handling 2Radiotherapy 2Radiosurgery 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Letrozole 2Irinotecan 2Gene Expression Profiling 2Fulvestrant 2Cisplatin 2Blood Specimen Collection 2Bevacizumab 2130-nm albumin-bound paclitaxel 2trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Diet Therapy × Sarcoma × Clear all
NCT00258401 2020-07-27

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Case Comprehensive Cancer Center

Phase NA Completed
11 enrolled
GenitourinaryGynecologicSarcoma

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Diarrhea, Prostatic Neoplasms, Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡